// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Survival after intrapleural catheter (IPC insertion for malignant pleural effusion (MPE: a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital

M.E.R. Shuvo - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The use of predicted vs actual haemoglobin in the calculation of gas transfer (TLCO in lung cancer pathways

Giles Dixon - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer

Mark Ambrose - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

The prevalence of occult N2/3 NSCLC in tumours with a central location, size larger than 3cm or N1 disease on imaging: a single-centre retrospective study

Felicity Liew - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Surveillance imaging and recurrence rates following surgery for non-small cell lung cancer (NSCLC

Liam Stapleton - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Evaluation of Primary care access to CT scans for patients suspected Lung Cancer with normal chest x-ray

Amrithraj Bhatta - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Accuracy of pre-operative staging of non-small cell lung cancer in the West of Scotland

Ahmed Alkarn - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

LSC - 2020 - Extracellular vesicles produced by bronchial epithelial cells in response to oxidative stress contain micro-RNAs associated with senescence

Justine Devulder - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Myeloid-derived microvesicles as acute mediators of sepsis-induced lung vascular inflammation

Diianeira Maria Tsiridou - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sepsis

N/A

Endoplasmic reticulum stress implication in senescence of small airway fibroblasts from COPD patients

Eva Delbrel - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Azithromycin maintains barrier integrity in a cell model of ventilator induced lung injury

Jon Joelsson - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Azithromycin

The effect of Clip-tone® and its smartphone application on optimization of metered-dose inhaler inhalation technique

Waleed Wael - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

“NIVSIM” a simulation based education (SBE intervention to improve the quality of care delivered for patients receiving acute non-invasive ventilation (NIV

Stephanie K. Mansell - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pleural procedure confidence and competence in postgraduate UK medical trainees

Andrew Singer - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pulmonary hypertension training requirements in the UK. A survey of UK respiratory trainees

Michael Bridgett - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Confidence of thrombolysis and follow up of acute pulmonary embolus in the UK. A survey of UK respiratory trainees

Michael Bridgett - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association between microbiome and plasma proteome profile in COPD

Mohammadali Yavari Ramsheh - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Comparative transcriptional analysis of differentiation in murine mucociliary epithelia

Md. Miraj Kobad Chowdhury - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Early exploratory use of omic approaches to assess metabolite changes in COPD

Tina Kramarić - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

Tamsulosin Hydrochloride

Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis

Jeffrey T.-J. Huang - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved